Skip to main content

Table 3 Pregnancy and neonatal outcome

From: The association between maternal cytomegalovirus urinary excretion and congenital infection rate

Parameter

Positive Urinary CMV

(n = 77)

Negative Urinary CMV

(n = 49)

p-value

Gestational age at delivery, weeks

38.6 ± 3.7

38.9 ± 1.7

0.588

Mode of deliverya

NVD

53 (68.9%)

36 (73.5%)

0.202

CD

12 (15.6%)

3 (6.1%)

OVD

3 (3.9%)

4 (8.2%)

Missing Data

2 (2.6%)

3 (6.1%)

Termination of Pregnancy

7 (9%)

3 (6.1%)

0.202

Birth weight, grams

3237.9 ± 382.8

3259.5 ± 437.4

0.792

Neonatal gender, male

34 (44.2%)

21 (42.9%)

0.842

Congenital CMV infectiona, b

Positive

26 (33.8%)

10 (20.4%)

0.209

Missing Data

7 (9%)

3 (6.1%)

 

Sonographic fetal findingsa

Positive

6 (7.8%)

5 (10.2%)

0.746

Missing Data

8 (10.4%)

7 (14.3%)

 

MRI findingsa

Positive

4 (5.2%)

4 (8.1%)

0.391

Missing

Data

7 (9%)

3 (6.1%)

 

Congenital CMV Diseasec

14 (18.2%)

11 (22.4%)

0.648

  1. Data presented as mean ± standard deviation for continuous variables and as n(%) for categorical variables
  2. NVD Normal Vaginal Delivery; CD Cesarean Delivery; OVD Operative Vaginal Delivery; TOP Termination of Pregnancy
  3. aData was missing in some of the women in the study groups
  4. bDetermined by amniocentesis or neonatal urine test
  5. cDefined by clinical neonatal findings and typical sonographic and fetal MRI findings